questionText: To ask the Secretary of State for Health and Social Care, what steps her Department is taking to support patients affected by shortages of Trulicity.
answerText: While the position has improved, there continues to be a global supply issue with glucagon-like peptide-1 receptor agonists (GLP-1 RA), including Trulicity (dulaglutide) and Ozempic (semaglutide). We have issued updated guidance to healthcare professional...
heading: Dulaglutide